Louis Pilon, president and CEO, highlights JAMP Pharma’s unique positioning as a Canadian generics company with one of the largest salesforce covering the whole Canadian market as well as the fourth-largest product portfolio, their focus on niche and complex products, their agility in seizing new opportunities, and his mission to take JAMP Pharma international over the next few years.
Louis, could you start by introducing JAMP Pharma to our international community?
"Our fundamental goal is to make a difference for our customers. We do this mainly by launching new and innovative generics products where there is significant market need."
